Please Wait.....
Report
Injection Pen Market Report and Forecast 2025-2034
Market Report I 2025-06-20 I 400 Pages I EMR Inc.
The global injection pen market was valued at USD 37.80 Billion in 2024 driven by the rising prevalence of chronic diseases and growing demand for self-administration devices across the globe. It is expected to grow at a CAGR of 7.20% during the forecast period of 2025-2034 and attain a market value of USD 75.76 Billion by 2034.
Injection Pen Market Overview
Injection pens are innovative medical devices designed for precise, user-friendly drug administration, widely used for conditions like diabetes, osteoporosis, and growth hormone deficiencies. The market is driven by the rising prevalence of chronic diseases and the growing demand for self-administration solutions. Key trends include advancements in smart pens and strategic collaborations. These factors, coupled with increased patient convenience are propelling the growth and adoption of injection pens globally.
Injection Pen Market Growth Drivers
Rising Prevalence of Chronic Disease Drives Market Growth
The rising prevalence of chronic disease significantly boosts the demand for injection pens. It offers an easy-to-use, patient-friendly solution, allowing for self-administration and improved adherence to treatment regimens. According to the World Health Organization 2023 data, non-communicable or chronic diseases were responsible for approximately 41 million deaths annually, accounting for 74% of all global fatalities. As conditions like diabetes, and rheumatoid arthritis become more common, patients require consistent and convenient administration of biologics and insulin therapies.
Injection Pen Market Trends
Several trends and developments are being observed in the market to enhance the current situation. The following are some of the noteworthy trends.
Expanding Applications to Drive Market Value
One of the key market trends include the expansion of the applications, which is driving growth in the market. For instance, in November 2024 Swiss company Ypsomed secured a contract with Novo Nordisk to supply injection pens for its promising obesity drug, CagriSema, poised to outperform Wegovy in weight loss. This highlighted Novo's commitment to its GLP-1 pipeline, with Ypsomed expanding its production capabilities to meet rising demand by 2025.
Strategic Collaborations to Boost Injection Pen Market Growth
Strategic collaborations are driving growth in the market significantly. For instance, in February 2023, Glooko partnered with Sanofi to enhance diabetes management by integrating SoloSmart with the Glooko platform. SoloSmart, a connected device for SoloStar and DoubleStar insulin pens, tracks insulin doses, dates, and times, enabling data sharing with healthcare professionals. This collaboration aimed to expand digital solutions to over 8,000 clinics globally. Such applications are expected to promote market growth in the forecast period significantly.
Surge in FDA Approvals to Strengthen Injection Pen Market Size
In February 2023, Amgen and AstraZeneca's TEZSPIRE injection pen received FDA approval for self-administration in a pre-filled, single-use setting. set to transform the injection pen market for severe asthma treatments. This approval, based on results from the PATHFINDER clinical trial program, allowed patients greater flexibility to administer TEZSPIRE at home. Such approvals are projected to significantly boost market growth by enhancing patient compliance and expanding treatment accessibility.
Increasing Demand for Self-Administration Devices to Boosting Injection Pen Market Value
One of the significant market trends is an increasing demand for self-administration devices among patients. It is driven by a growing focus on patient empowerment and convenience. As more biologics and other treatments become available for self-injection, patients are seeking easier-to-use, at-home solutions. This trend is further supported by advancements in technology, leading to the development of more ergonomic, user-friendly injection pens that enhance the overall patient experience.
Injection Pen Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
- Disposable
- Re-Usable
Market Breakup by Therapy
- Diabetes
- Insulin
- GLP-1
- Growth Hormone Therapy
- Osteoporosis
- Fertility
- Others
Market Breakup by End User
- Home Care Settings
- Hospitals
- Speciality Clinics
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Injection Pen Market Share
Market Share by Type to Witness Significant Growth
Based on the type, the market is divided into disposable and re-usable. Among these, disposable is expected to lead the market during the forecast period, owing to a rise in the adoption of disposable injection pens across the globe. In addition, there is a focus on preventing the risk of cross-contamination and needle stick injuries associated with reusable injection pens. As healthcare professionals and patients prioritize safety, the demand for disposable type is likely to rise steadily in the forecast period.
Injection Pen Market Analysis by Region
Based on region, the market report covers North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. Among these, North America is expected to dominate the market due to the presence of robust healthcare infrastructure and the prominent key players in the region. Companies like Novo Nordisk and Sanofi are heavily investing in research and development to come up with innovative products.
Leading Players in the Injection Pen Market
The key features of the market report include patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies are:
Pfizer Inc.
Established in 1849, Pfizer is headquartered in New York, USA. The company has developed the Genotropin Pen, an advanced injection pen for administering human growth hormone therapy. The pen simplifies dosage adjustments and ensures precise delivery, offering convenience and improved treatment adherence for patients requiring growth hormone replacement therapy.
Novartis AG
Founded in 1996 and headquartered in Basel, Switzerland, Novartis developed the Revolizer, a reusable injection pen system designed for delivering respiratory drugs. This innovative device enhances dose accuracy and patient convenience, supporting its commitment to improving drug delivery solutions across multiple therapeutic areas.
Novo Nordisk A/S
Founded in 1923, Novo Nordisk A/S is headquartered in Denmark. The company is renowned for its FlexTouch and FlexPen insulin pens, which are widely used for diabetes management. These pens ensure accurate insulin delivery, ease of use, and enhanced patient compliance, establishing Novo Nordisk as a leader in the market.
Sanofi SA
Established in 1973, Sanofi SA is headquartered in Paris, France. The company has developed the SoloStar insulin injection pen, a widely used device for managing diabetes. The pen is designed for precision, convenience, and ease of use, helping patients maintain effective glucose control and improving their overall diabetes management experience.
Other companies include Becton, Dickinson and Company, Eli Lilly and Company, Ypsomed AG, Biocon Biologics Limited, Owen Mumford Ltd., and Merck KGaA.
Key Questions Answered in the Injection Pen Market
- What was the global injection pen market value in 2024?
- What is the global injection pen market forecast outlook for 2025-2034?
- What are the regional markets covered in the EMR report?
- What is the market segmentation based on the type?
- What is the market breakup based on the therapy?
- What is the market segmentation based on the end user?
- What are the major factors aiding the global injection pen market demand?
- What are the market's major drivers, opportunities, and restraints?
- Which regional market is expected to lead the market share in the forecast period?
- Which country is expected to experience expedited growth during the forecast period?
- What are the major global injection pen market trends?
- How does the rise in the geriatric population impact the market size?
- Who are the key players involved in the global injection pen market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Injection Pen Market Overview
3.1 Global Injection Pen Market Historical Value (2018-2024)
3.2 Global Injection Pen Market Forecast Value (2025-2034)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Injection Pen Market Landscape*
5.1 Global Injection Pen Market: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Injection Pen Market: Product Landscape
5.2.1 Analysis by Type
5.2.2 Analysis by Therapy
6 Global Injection Pen Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter's Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Injection Pen Market Segmentation (218-2034)
7.1 Global Injection Pen Market (2018-2034) by Type
7.1.1 Market Overview
7.1.2 Disposable
7.1.3 Re-Usable
7.2 Global Injection Pen Market (2018-2034) by Therapy
7.2.1 Market Overview
7.2.2 Diabetes
7.2.2.1 Insulin
7.2.2.2 GLP-1
7.2.3 Growth Hormone Therapy
7.2.4 Osteoporosis
7.2.5 Fertility
7.2.6 Others
7.3 Global Injection Pen Market (2018-2034) by End User
7.3.1 Market Overview
7.3.2 Home Care Settings
7.3.3 Hospitals
7.3.4 Specialty Clinics
7.4 Global Injection Pen Market (2018-2034) by Region
7.4.1 Market Overview
7.4.2 North America
7.4.3 Europe
7.4.4 Asia Pacific
7.4.5 Latin America
7.4.6 Middle East and Africa
8 North America Injection Pen Market (218-2034)
8.1 North America Injection Pen Market (2018-2034) by Type
8.1.1 Market Overview
8.1.2 Disposable
8.1.3 Re-Usable
8.2 North America Injection Pen Market (2018-2034) by Therapy
8.2.1 Market Overview
8.2.2 Diabetes
8.2.2.1 Insulin
8.2.2.2 GLP-1
8.2.3 Growth Hormone Therapy
8.2.4 Osteoporosis
8.2.5 Fertility
8.2.6 Others
8.3 North America Injection Pen Market (2018-2034) by End User
8.3.1 Market Overview
8.3.2 Home Care Settings
8.3.3 Hospitals
8.3.4 Specialty Clinics
8.4 North America Injection Pen Market (2018-2034) by Country
8.4.1 United States of America
8.4.1.1 United States of America Injection Pen Market Size, by Type
8.4.2 Canada
8.4.2.1 Canada Injection Pen Market Size, by Type
9 Europe Injection Pen Market (218-2034)
9.1 Europe Injection Pen Market (2018-2034) by Type
9.1.1 Market Overview
9.1.2 Disposable
9.1.3 Re-Usable
9.2 Europe Injection Pen Market (2018-2034) by Therapy
9.2.1 Market Overview
9.2.2 Diabetes
9.2.2.1 Insulin
9.2.2.2 GLP-1
9.2.3 Growth Hormone Therapy
9.2.4 Osteoporosis
9.2.5 Fertility
9.2.6 Others
9.3 Europe Injection Pen Market (2018-2034) by End User
9.3.1 Market Overview
9.3.2 Home Care Settings
9.3.3 Hospitals
9.3.4 Specialty Clinics
9.4 Europe Injection Pen Market (2018-2034) by Country
9.4.1 United Kingdom
9.4.1.1 United Kingdom Injection Pen Market Size, by Type
9.4.2 Germany
9.4.2.1 Germany Injection Pen Market Size, by Type
9.4.3 France
9.4.3.1 France Injection Pen Market Size, by Type
9.4.4 Italy
9.4.4.1 Italy Injection Pen Market Size, by Type
9.4.5 Others
10 Asia Pacific Injection Pen Market (218-2034)
10.1 Asia Pacific Injection Pen Market (2018-2034) by Type
10.1.1 Market Overview
10.1.2 Disposable
10.1.3 Re-Usable
10.2 Asia Pacific Injection Pen Market (2018-2034) by Therapy
10.2.1 Market Overview
10.2.2 Diabetes
10.2.2.1 Insulin
10.2.2.2 GLP-1
10.2.3 Growth Hormone Therapy
10.2.4 Osteoporosis
10.2.5 Fertility
10.2.6 Others
10.3 Asia Pacific Injection Pen Market (2018-2034) by End User
10.3.1 Market Overview
10.3.2 Home Care Settings
10.3.3 Hospitals
10.3.4 Specialty Clinics
10.4 Asia Pacific Injection Pen Market (2018-2034) by Country
10.4.1 China
10.4.1.1 China Injection Pen Market Size, by Type
10.4.2 Japan
10.4.2.1 Japan Injection Pen Market Size, by Type
10.4.3 India
10.4.3.1 India Injection Pen Market Size, by Type
10.4.4 ASEAN
10.4.4.1 ASEAN Injection Pen Market Size, by Type
10.4.5 Australia
10.4.5.1 Australia Injection Pen Market Size, by Type
10.4.6 Others
11 Latin America Injection Pen Market (218-2034)
11.1 Latin America Injection Pen Market (2018-2034) by Type
11.1.1 Market Overview
11.1.2 Disposable
11.1.3 Re-Usable
11.2 Latin America Injection Pen Market (2018-2034) by Therapy
11.2.1 Market Overview
11.2.2 Diabetes
11.2.2.1 Insulin
11.2.2.2 GLP-1
11.2.3 Growth Hormone Therapy
11.2.4 Osteoporosis
11.2.5 Fertility
11.2.6 Others
11.3 Latin America Injection Pen Market (2018-2034) by End User
11.3.1 Market Overview
11.3.2 Home Care Settings
11.3.3 Hospitals
11.3.4 Specialty Clinics
11.4 Latin America Injection Pen Market (2018-2034) by Country
11.4.1 Brazil
11.4.1.1 Brazil Injection Pen Market Size, by Type
11.4.2 Argentina
11.4.2.1 Argentina Injection Pen Market Size, by Type
11.4.3 Mexico
11.4.3.1 Mexico Injection Pen Market Size, by Type
11.4.4 Others
12 Middle East and Africa Injection Pen Market (218-2034)
12.1 Middle East and Africa Injection Pen Market (2018-2034) by Type
12.1.1 Market Overview
12.1.2 Disposable
12.1.3 Re-Usable
12.2 Middle East and Africa Injection Pen Market (2018-2034) by Therapy
12.2.1 Market Overview
12.2.2 Diabetes
12.2.2.1 Insulin
12.2.2.2 GLP-1
12.2.3 Growth Hormone Therapy
12.2.4 Osteoporosis
12.2.5 Fertility
12.2.6 Others
12.3 Middle East and Africa Injection Pen Market (2018-2034) by End User
12.3.1 Market Overview
12.3.2 Home Care Settings
12.3.3 Hospitals
12.3.4 Specialty Clinics
12.4 Middle East and Africa Injection Pen Market (2018-2034) by Country
12.4.1 Saudi Arabia
12.4.1.1 Saudi Arabia Injection Pen Market Size, by Type
12.4.2 United Arab Emirates
12.4.2.1 United Arab Emirates Injection Pen Market Size, by Type
12.4.3 Nigeria
12.4.3.1 Nigeria Injection Pen Market Size, by Type
12.4.4 South Africa
12.4.4.1 South Africa Injection Pen Market Size, by Type
12.4.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 Japan PMDA
13.5 India CDSCO
13.6 Others
14 Patent Analysis
14.1 Analysis by Type of Patent
14.2 Analysis by Publication Year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Analysis
14.6 Analysis by Patent Valuation
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Drug Class of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Strategic Initiatives
16.1 Analysis by Partnership Instances
16.2 Analysis by Drug Class of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Market Share Analysis, By Region (Top 5 Companies)
17.1.1 Market Share Analysis: Global
17.1.2 Market Share Analysis: North America
17.1.3 Market Share Analysis: Europe
17.1.4 Market Share Analysis: Asia Pacific
17.1.5 Market Share Analysis: Others
17.2 Becton, Dickinson and Company
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Company News and Development
17.2.5 Certifications
17.3 Eli Lilly and Company
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Company News and Development
17.3.5 Certifications
17.4 Ypsomed AG
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Company News and Development
17.4.5 Certifications
17.5 Biocon Biologics Limited
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Company News and Development
17.5.5 Certifications
17.6 Pfizer Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Company News and Development
17.6.5 Certifications
17.7 Novartis AG
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Company News and Development
17.7.5 Certifications
17.8 Novo Nordisk A/S
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Company News and Development
17.8.5 Certifications
17.9 Sanofi SA
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Company News and Development
17.9.5 Certifications
17.10 Owen Mumford Ltd.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Company News and Development
17.10.5 Certifications
17.11 Merck KGaA
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Company News and Development
17.11.5 Certifications
18 Global Injection Pen Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security